10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001144204-18-028920 |
| Period End Date | 20180331 |
| Filing Date | 20180515 |
| Fiscal Year | 2018 |
| Fiscal Period | Q1 |
| XBRL Instance | ameh-20180331.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
94 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$63.25M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$103.73M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$99.75M | USD | Point-in-time |
| Restricted cash - short-term |
RestrictedCashCurrent
|
$18.01M | USD | Point-in-time |
| Restricted cash - short-term |
RestrictedCashCurrent
|
- | USD | Point-in-time |
| Restricted cash - short-term |
RestrictedCashCurrent
|
$18.03M | USD | Point-in-time |
| Fiduciary cash |
AssetsHeldInTrustCurrent
|
$1.39M | USD | Point-in-time |
| Fiduciary cash |
AssetsHeldInTrustCurrent
|
$2.02M | USD | Point-in-time |
| Common Stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common Stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common Stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Investment in marketable securities |
MarketableSecuritiesCurrent
|
$1.14M | USD | Point-in-time |
| Common Stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Investment in marketable securities |
MarketableSecuritiesCurrent
|
$1.14M | USD | Point-in-time |
| Common Stock, shares outstanding |
CommonStockSharesOutstanding
|
32.30M | shares | Point-in-time |
| Receivables, net |
AccountsReceivableNetCurrent
|
$52.81M | USD | Point-in-time |
| Common Stock, shares outstanding |
CommonStockSharesOutstanding
|
32.65M | shares | Point-in-time |
| Receivables, net |
AccountsReceivableNetCurrent
|
$20.12M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$3.13M | USD | Point-in-time |
| Treasury Stock, Common, Shares |
TreasuryStockCommonShares
|
1.68M | shares | Point-in-time |
| Treasury Stock, Common, Shares |
TreasuryStockCommonShares
|
1.68M | shares | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$3.53M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$144.16M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$180.62M | USD | Point-in-time |
| Land, property and equipment, net |
PropertyPlantAndEquipmentNet
|
$13.81M | USD | Point-in-time |
| Land, property and equipment, net |
PropertyPlantAndEquipmentNet
|
$13.70M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$103.53M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$99.14M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$188.93M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$189.85M | USD | Point-in-time |
| Loans receivable - related parties |
DueFromRelatedPartiesNoncurrent
|
$5.00M | USD | Point-in-time |
| Loans receivable - related parties |
DueFromRelatedPartiesNoncurrent
|
$5.00M | USD | Point-in-time |
| Loan receivable |
LoansReceivableNet
|
$10.00M | USD | Point-in-time |
| Loan receivable |
LoansReceivableNet
|
$10.00M | USD | Point-in-time |
| Investments in other entities - equity method |
EquityMethodInvestments
|
$21.88M | USD | Point-in-time |
| Investments in other entities - equity method |
EquityMethodInvestments
|
$21.90M | USD | Point-in-time |
| Restricted cash - long-term |
RestrictedCashNoncurrent
|
$745.24K | USD | Point-in-time |
| Restricted cash - long-term |
RestrictedCashNoncurrent
|
$101.13K | USD | Point-in-time |
| Restricted cash - long-term |
RestrictedCashNoncurrent
|
$745.29K | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$1.63M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$1.59M | USD | Point-in-time |
| Total noncurrent assets |
AssetsNoncurrent
|
$346.48M | USD | Point-in-time |
| Total noncurrent assets |
AssetsNoncurrent
|
$340.98M | USD | Point-in-time |
| Total assets |
Assets
|
$521.59M | USD | Point-in-time |
| Total assets |
Assets
|
$490.64M | USD | Point-in-time |
| Lines of credit |
LinesOfCreditCurrent
|
$5.03M | USD | Point-in-time |
| Lines of credit |
LinesOfCreditCurrent
|
$5.00M | USD | Point-in-time |
| Accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$12.11M | USD | Point-in-time |
| Accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$13.28M | USD | Point-in-time |
| Incentives payable |
IncentivePayableCurrent
|
$14.90M | USD | Point-in-time |
| Incentives payable |
IncentivePayableCurrent
|
$21.50M | USD | Point-in-time |
| Fiduciary accounts payable |
FiduciaryAccountsPayableCurrent
|
$2.02M | USD | Point-in-time |
| Fiduciary accounts payable |
FiduciaryAccountsPayableCurrent
|
$1.39M | USD | Point-in-time |
| Medical liabilities |
MedicalLiabilitiesCurrent
|
$63.97M | USD | Point-in-time |
| Medical liabilities |
MedicalLiabilitiesCurrent
|
$69.11M | USD | Point-in-time |
| Medical liabilities |
MedicalLiabilitiesCurrent
|
$18.96M | USD | Point-in-time |
| Income taxes payable |
AccruedIncomeTaxesCurrent
|
$3.20M | USD | Point-in-time |
| Income taxes payable |
AccruedIncomeTaxesCurrent
|
$7.61M | USD | Point-in-time |
| Bank loan, short-term |
ShortTermBankLoansAndNotesPayable
|
$510.39K | USD | Point-in-time |
| Bank loan, short-term |
ShortTermBankLoansAndNotesPayable
|
$394.78K | USD | Point-in-time |
| Capital lease obligations |
CapitalLeaseObligationsCurrent
|
$98.74K | USD | Point-in-time |
| Capital lease obligations |
CapitalLeaseObligationsCurrent
|
$99.48K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$109.60M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$110.62M | USD | Point-in-time |
| Deferred tax liability |
DeferredTaxLiabilities
|
$24.92M | USD | Point-in-time |
| Deferred tax liability |
DeferredTaxLiabilities
|
$30.06M | USD | Point-in-time |
| Liability for unissued equity shares |
LiabilityForUnissuedEquitySharesNoncurrent
|
$1.19M | USD | Point-in-time |
| Liability for unissued equity shares |
LiabilityForUnissuedEquitySharesNoncurrent
|
$1.19M | USD | Point-in-time |
| Dividends payable |
DividendPayableNoncurrent
|
$18.00M | USD | Point-in-time |
| Dividends payable |
DividendPayableNoncurrent
|
$18.00M | USD | Point-in-time |
| Capital lease obligations, net of current portion |
CapitalLeaseObligationsNoncurrent
|
$593.85K | USD | Point-in-time |
| Capital lease obligations, net of current portion |
CapitalLeaseObligationsNoncurrent
|
$619.00K | USD | Point-in-time |
| Total noncurrent liabilities |
LiabilitiesNoncurrent
|
$44.72M | USD | Point-in-time |
| Total noncurrent liabilities |
LiabilitiesNoncurrent
|
$49.83M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$160.45M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$154.32M | USD | Point-in-time |
| Commitments and Contingencies (Note 11) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and Contingencies (Note 11) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Noncontrolling interest in Allied Pacific of California IPA (APC) |
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
|
$190.65M | USD | Point-in-time |
| Noncontrolling interest in Allied Pacific of California IPA (APC) |
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
|
$172.13M | USD | Point-in-time |
| Common stock, par value $0.001; 100,000,000 shares authorized, 32,652,295 and 32,304,876 shares outstanding, excluding 1,682,110 shares held by APC, at March 31, 2018 and December 31, 2017, respectively (see Note 10) |
CommonStockValue
|
$32.30K | USD | Point-in-time |
| Common stock, par value $0.001; 100,000,000 shares authorized, 32,652,295 and 32,304,876 shares outstanding, excluding 1,682,110 shares held by APC, at March 31, 2018 and December 31, 2017, respectively (see Note 10) |
CommonStockValue
|
$32.65K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$158.18M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$160.74M | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$1.73M | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$4.90M | USD | Point-in-time |
| Stockholders' Equity Attributable to Parent |
StockholdersEquity
|
$165.67M | USD | Point-in-time |
| Stockholders' Equity Attributable to Parent |
StockholdersEquity
|
$159.95M | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$4.82M | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$4.24M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$164.18M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$170.49M | USD | Point-in-time |
| Total liabilities, mezzanine equity and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$490.64M | USD | Point-in-time |
| Total liabilities, mezzanine equity and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$521.59M | USD | Point-in-time |
Income Statement
52 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Capitation, net |
HealthCareOrganizationCapitationRevenue
|
$85.91M | USD | 1 Quarter |
| Capitation, net |
HealthCareOrganizationCapitationRevenue
|
$64.72M | USD | 1 Quarter |
| Risk pool settlements and incentives |
HealthCareOrganizationOtherRevenue
|
$11.14M | USD | 1 Quarter |
| Risk pool settlements and incentives |
HealthCareOrganizationOtherRevenue
|
$17.99M | USD | 1 Quarter |
| Management fee income |
ManagementFeesRevenue
|
$12.07M | USD | 1 Quarter |
| Management fee income |
ManagementFeesRevenue
|
$6.54M | USD | 1 Quarter |
| Fee-for-service, net |
HealthCareOrganizationPatientServiceRevenue
|
$7.75M | USD | 1 Quarter |
| Fee-for-service, net |
HealthCareOrganizationPatientServiceRevenue
|
$2.66M | USD | 1 Quarter |
| Other income |
OtherSalesRevenueNet
|
$281.71K | USD | 1 Quarter |
| Other income |
OtherSalesRevenueNet
|
$452.03K | USD | 1 Quarter |
| Total revenue |
SalesRevenueNet
|
$124.17M | USD | 1 Quarter |
| Total revenue |
SalesRevenueNet
|
$85.34M | USD | 1 Quarter |
| Cost of services |
CostOfServices
|
$84.67M | USD | 1 Quarter |
| Cost of services |
CostOfServices
|
$59.61M | USD | 1 Quarter |
| General and administrative expenses |
GeneralAndAdministrativeExpense
|
$5.21M | USD | 1 Quarter |
| General and administrative expenses |
GeneralAndAdministrativeExpense
|
$11.74M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$5.06M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$4.84M | USD | 1 Quarter |
| Total expenses |
OperatingExpenses
|
$69.66M | USD | 1 Quarter |
| Total expenses |
OperatingExpenses
|
$101.47M | USD | 1 Quarter |
| Income from operations |
OperatingIncomeLoss
|
$15.68M | USD | 1 Quarter |
| Income from operations |
OperatingIncomeLoss
|
$22.70M | USD | 1 Quarter |
| (Loss) income from equity method investments |
IncomeLossFromEquityMethodInvestments
|
$2.23M | USD | 1 Quarter |
| (Loss) income from equity method investments |
IncomeLossFromEquityMethodInvestments
|
$-28.02K | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$85.00K | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$811.00 | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$269.82K | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$182.28K | USD | 1 Quarter |
| Change in fair value of derivative instrument |
GainLossOnDerivativeInstrumentsNetPretax
|
$1.52M | USD | 1 Quarter |
| Change in fair value of derivative instrument |
GainLossOnDerivativeInstrumentsNetPretax
|
- | USD | 1 Quarter |
| Other income |
OtherNonoperatingIncomeExpense
|
$87.99K | USD | 1 Quarter |
| Other income |
OtherNonoperatingIncomeExpense
|
$1.51K | USD | 1 Quarter |
| Total other income, net |
NonoperatingIncomeExpense
|
$244.79K | USD | 1 Quarter |
| Total other income, net |
NonoperatingIncomeExpense
|
$3.93M | USD | 1 Quarter |
| Income before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$22.95M | USD | 1 Quarter |
| Income before provision for income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$19.61M | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$7.89M | USD | 1 Quarter |
| Provision for income taxes |
IncomeTaxExpenseBenefit
|
$7.23M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$11.72M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$15.72M | USD | 1 Quarter |
| Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$7.37M | USD | 1 Quarter |
| Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$13.56M | USD | 1 Quarter |
| Net income attributable to Apollo Medical Holdings, Inc. |
NetIncomeLoss
|
$4.35M | USD | 1 Quarter |
| Net income attributable to Apollo Medical Holdings, Inc. |
NetIncomeLoss
|
$2.16M | USD | 1 Quarter |
| Earnings per share - basic |
EarningsPerShareBasic
|
$0.17 | USD | 1 Quarter |
| Earnings per share - basic |
EarningsPerShareBasic
|
$0.07 | USD | 1 Quarter |
| Earnings per share - diluted |
EarningsPerShareDiluted
|
$0.15 | USD | 1 Quarter |
| Earnings per share - diluted |
EarningsPerShareDiluted
|
$0.06 | USD | 1 Quarter |
| Weighted average shares of common stock outstanding - basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
25.07M | shares | 1 Quarter |
| Weighted average shares of common stock outstanding - basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
32.42M | shares | 1 Quarter |
| Weighted average shares of common stock outstanding - diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
38.10M | shares | 1 Quarter |
| Weighted average shares of common stock outstanding - diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
28.45M | shares | 1 Quarter |
Cash Flow Statement
95 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$11.72M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$15.72M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$5.06M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$4.84M | USD | 1 Quarter |
| Loss on disposal of property and equipment |
GainLossOnSaleOfPropertyPlantEquipment
|
- | USD | 1 Quarter |
| Loss on disposal of property and equipment |
GainLossOnSaleOfPropertyPlantEquipment
|
$-41.78K | USD | 1 Quarter |
| Share-based compensation |
AllocatedShareBasedCompensationExpense
|
$321.23K | USD | 1 Quarter |
| Share-based compensation |
AllocatedShareBasedCompensationExpense
|
$833.94K | USD | 1 Quarter |
| Unrealized loss from investment in equity securities |
UnrealizedGainLossOnInvestments
|
$-8.55K | USD | 1 Quarter |
| Unrealized loss from investment in equity securities |
UnrealizedGainLossOnInvestments
|
- | USD | 1 Quarter |
| Change in fair value of derivative instrument |
GainLossOnDerivativeInstrumentsNetPretax
|
$1.52M | USD | 1 Quarter |
| Change in fair value of derivative instrument |
GainLossOnDerivativeInstrumentsNetPretax
|
- | USD | 1 Quarter |
| Loss (income) from equity method investments |
IncomeLossFromEquityMethodInvestments
|
$2.23M | USD | 1 Quarter |
| Loss (income) from equity method investments |
IncomeLossFromEquityMethodInvestments
|
$-28.02K | USD | 1 Quarter |
| Deferred tax |
DeferredIncomeTaxExpenseBenefit
|
$2.11M | USD | 1 Quarter |
| Deferred tax |
DeferredIncomeTaxExpenseBenefit
|
$2.81M | USD | 1 Quarter |
| Receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$21.09M | USD | 1 Quarter |
| Receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$-14.41M | USD | 1 Quarter |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
|
$398.57K | USD | 1 Quarter |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
|
$428.87K | USD | 1 Quarter |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$54.37K | USD | 1 Quarter |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$59.44K | USD | 1 Quarter |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-1.17M | USD | 1 Quarter |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-2.35M | USD | 1 Quarter |
| Incentives payable |
IncreaseDecreaseInIncentivesPayable
|
$-6.60M | USD | 1 Quarter |
| Incentives payable |
IncreaseDecreaseInIncentivesPayable
|
$-9.72M | USD | 1 Quarter |
| Medical liabilities |
IncreaseDecreaseInMedicalLiabilities
|
$-257.94K | USD | 1 Quarter |
| Medical liabilities |
IncreaseDecreaseInMedicalLiabilities
|
$5.14M | USD | 1 Quarter |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$4.42M | USD | 1 Quarter |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$4.27M | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$4.74M | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$21.11M | USD | 1 Quarter |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$1.30K | USD | 1 Quarter |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$3.93K | USD | 1 Quarter |
| Advances to related parties - loans receivable |
PaymentsToFundLongtermLoansToRelatedParties
|
$5.00M | USD | 1 Quarter |
| Advances to related parties - loans receivable |
PaymentsToFundLongtermLoansToRelatedParties
|
- | USD | 1 Quarter |
| Dividends received from equity method investments |
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
|
- | USD | 1 Quarter |
| Dividends received from equity method investments |
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
|
$1.00M | USD | 1 Quarter |
| Proceeds on sale of investments - cost method |
ProceedsFromSaleOfCostMethodInvestments
|
$25.00K | USD | 1 Quarter |
| Proceeds on sale of investments - cost method |
ProceedsFromSaleOfCostMethodInvestments
|
- | USD | 1 Quarter |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$318.82K | USD | 1 Quarter |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$485.12K | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-4.30M | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-489.05K | USD | 1 Quarter |
| Repayment of bank loan |
RepaymentsOfRelatedPartyDebt
|
- | USD | 1 Quarter |
| Repayment of bank loan |
RepaymentsOfRelatedPartyDebt
|
$140.61K | USD | 1 Quarter |
| Dividends paid |
PaymentsOfDividends
|
$2.00M | USD | 1 Quarter |
| Dividends paid |
PaymentsOfDividends
|
$8.75M | USD | 1 Quarter |
| Change in noncontrolling interest capital |
ProceedsFromPaymentsToMinorityShareholders
|
$-27.50K | USD | 1 Quarter |
| Change in noncontrolling interest capital |
ProceedsFromPaymentsToMinorityShareholders
|
- | USD | 1 Quarter |
| Payment of capital lease obligations |
RepaymentsOfDebtAndCapitalLeaseObligations
|
$30.98K | USD | 1 Quarter |
| Payment of capital lease obligations |
RepaymentsOfDebtAndCapitalLeaseObligations
|
$24.41K | USD | 1 Quarter |
| Proceeds from exercise of stock options and warrants |
ProceedsFromStockOptionsExercised
|
$1.92M | USD | 1 Quarter |
| Proceeds from exercise of stock options and warrants |
ProceedsFromStockOptionsExercised
|
$425.02K | USD | 1 Quarter |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-241.23K | USD | 1 Quarter |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-8.38M | USD | 1 Quarter |
| Net increase in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
$8.43M | USD | 1 Quarter |
| Net increase in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
$4.01M | USD | 1 Quarter |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$122.51M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$54.93M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$118.50M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$63.35M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$122.51M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$54.93M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$118.50M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$63.35M | USD | Point-in-time |
| Cash paid for income taxes |
IncomeTaxesPaid
|
- | USD | 1 Quarter |
| Cash paid for income taxes |
IncomeTaxesPaid
|
$1.51M | USD | 1 Quarter |
| Cash paid for interest |
InterestPaidNet
|
$73.61K | USD | 1 Quarter |
| Cash paid for interest |
InterestPaidNet
|
$811.00 | USD | 1 Quarter |
| Cashless exercise of stock options |
CashlessExerciseOfStockOptions
|
- | USD | 1 Quarter |
| Cashless exercise of stock options |
CashlessExerciseOfStockOptions
|
$43.00 | USD | 1 Quarter |
| Reclassification of stock options exercised to liability for unissued common shares |
StockIssued1
|
- | USD | 1 Quarter |
| Reclassification of stock options exercised to liability for unissued common shares |
StockIssued1
|
$425.02K | USD | 1 Quarter |
| Deferred tax liability adjustment to goodwill |
DeferredTaxLiabilityAdjustmentToGoodwill
|
$914.01K | USD | 1 Quarter |
| Deferred tax liability adjustment to goodwill |
DeferredTaxLiabilityAdjustmentToGoodwill
|
- | USD | 1 Quarter |
| Cumulative effect adjustment for ASC 606 included in accounts receivable |
CumulativeEffectAdjustmentIncludedInAccountsReceivable
|
- | USD | 1 Quarter |
| Cumulative effect adjustment for ASC 606 included in accounts receivable |
CumulativeEffectAdjustmentIncludedInAccountsReceivable
|
$11.60M | USD | 1 Quarter |
| Cumulative effect adjustment for ASC 606 included in deferred tax liabilities |
CumulativeEffectAdjustmentIncludedInDeferredTaxLiabilities
|
$3.25M | USD | 1 Quarter |
| Cumulative effect adjustment for ASC 606 included in deferred tax liabilities |
CumulativeEffectAdjustmentIncludedInDeferredTaxLiabilities
|
- | USD | 1 Quarter |
| Reclassification of fiduciary cash to payable |
LiabilitiesAssumed1
|
$32.48K | USD | 1 Quarter |
| Reclassification of fiduciary cash to payable |
LiabilitiesAssumed1
|
$630.96K | USD | 1 Quarter |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$63.25M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$103.73M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$99.75M | USD | Point-in-time |
| Restricted cash - long-term - letters of credit |
RestrictedCashNoncurrent
|
$745.24K | USD | Point-in-time |
| Restricted cash - long-term - letters of credit |
RestrictedCashNoncurrent
|
$101.13K | USD | Point-in-time |
| Restricted cash - long-term - letters of credit |
RestrictedCashNoncurrent
|
$745.29K | USD | Point-in-time |
| Restricted cash - short-term - distributions to former NMM shareholders |
RestrictedCashCurrent
|
$18.01M | USD | Point-in-time |
| Restricted cash - short-term - distributions to former NMM shareholders |
RestrictedCashCurrent
|
- | USD | Point-in-time |
| Restricted cash - short-term - distributions to former NMM shareholders |
RestrictedCashCurrent
|
$18.03M | USD | Point-in-time |
| Total cash, cash equivalents, and restricted cash shown in the statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$122.51M | USD | Point-in-time |
| Total cash, cash equivalents, and restricted cash shown in the statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$54.93M | USD | Point-in-time |
| Total cash, cash equivalents, and restricted cash shown in the statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$118.50M | USD | Point-in-time |
| Total cash, cash equivalents, and restricted cash shown in the statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$63.35M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.